The global medical thawing system market size is expected to reach USD 355.9 million by 2030, registering a CAGR of 8.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growing demand for medical thawing systems in blood banks and laboratories, where it requires warming of products such as crystalloid infusion solution, whole blood, and RBC before transfusion into a patient, is expected to drive the growth. Technological advancements in automated thaw systems at the point of care settings and rising demand for rapid thawing techniques of frozen plasma in various surgical procedures are the factors augmenting the market growth. Besides, the rising use of thawed cells due to the high incidence of road accidents, diabetes, cancer, and trauma cases are also creating demand.
The rising number of surgical procedures and increasing incidence of hemorrhage related conditions in these surgical procedures are driving the healthcare thawing system market growth. Rising demand for thawed blood to be more rapidly available for hemorrhage in various invasive surgical procedures is the major contributor to the market growth. Moreover, the increasing number of product launches and continuous improvement in the features of the thaw system is also contributing to the demand. The increasing number of embryo donors and the rising awareness about third-party reproduction is also augmenting the demand for thawing systems. According to the Centers for Disease Control and Prevention, there were more than 2.6 lakhs attempts at in vitro fertilization in 2016.
Request a free sample copy or view report summary: Medical Thawing System Market Report
Manual thawing systems led the market with a revenue share of 56.6% in 2024, owing to their cost-effectiveness and extensive product variety.
The blood segment dominated the market and accounted for a share of 52.6% in 2024. The demand for rapid thawing of blood products in emergency and surgical settings is escalating, driven by the increasing volume of surgical procedures and the critical need for thawed blood in hemorrhage cases.
Blood banks & transfusion centers held the largest share of 31.4% in 2024. The demand for rapid thawing of blood products, especially fresh frozen plasma and red blood cells for emergency transfusions, is increasing.
North America medical thawing system market dominated the global market with a revenue share of 47.3% in 2024.
Grand View Research has segmented global medical thawing system market report based on type, sample, end-use, and region:
Medical Thawing System Type Outlook (Revenue, USD Million, 2018 - 2030)
Manual
Automated
Medical Thawing System Sample Outlook (Revenue, USD Million, 2018 - 2030)
Blood
Embryo
Ovum
Semen
Others
Medical Thawing System End-use Outlook (Revenue, USD Million, 2018 - 2030)
Blood Banks & Transfusion Centers
Hospitals
Tissue Banks
Biotechnology & Pharma
Others
Medical Thawing System Regional Outlook (Revenue, USD Billion, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players of Medical Thawing System Market
Helmer Scientific Inc.
SARSTEDT AG & Co. KG
Azenta US, Inc.
GE HealthCare
Boekel Scientific
Barkey
Cardinal Health
Thermo Fisher Scientific Inc.
Cytotherm
"The quality of research they have done for us has been excellent..."